Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
6/13/2025
Kelun Cleared for Clinical Trial of SKB315 and Tagitanlimab Combo in C...
6/12/2025
Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...
6/12/2025
Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...
6/11/2025
JW Pharma Wins China Approval for Ertapenem Injection
6/11/2025
3Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...
6/10/2025
6/10/2025
GenEditBio Doses First Patient in World’s First In Vivo CRISPR Trial ...
6/9/2025
Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted
6/9/2025
Livzon's siRNA Candidate YJH‑012 Approved for Clinical Entry in China
6/9/2025
Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hypertension
6/6/2025
Beigene's BGB‑16673 Enters Phase 1b Trial for Chronic Urticaria in Ch...
6/6/2025
Qilu Launches Phase III Trial of QL1706 + Bevacizumab
6/6/2025
BMS's Reblozyl Approved in China for Lower‑Risk MDS‑Related Anemia
6/6/2025
AstraZeneca's Imfinzi Approved in China for LS‑SCLC
6/6/2025
Keymed Launches First-in-Human Trial of CM518D1
6/6/2025
AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...
6/6/2025
Kelun‑Biotech Initiates Phase II Trial of PTK7‑Targeted ADC SKB518 i...
6/6/2025
Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...
6/5/2025
CSPC Receives Chinese Approval for Cobamamide Capsules to Treat Anemia
6/5/2025
Ascletis's Denifanstat Shows Promising Results in Phase III Acne Trial
6/4/2025
Biocytogen and CTTQ Receive IND Approval in China for Next-Gen Anti-IG...
6/4/2025
China Approves First Homegrown 9-Valent HPV Vaccine
6/4/2025
Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...
6/3/2025
Leads Biolabs' LBL-024 Shows Promising Results in EP-NEC Treatment
6/3/2025
Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer
6/3/2025
CTTQ Achieves Breakthrough in Lung Cancer Treatment
6/3/2025
Transcenta's Triple Therapy Shows Promising Results for G/GEJ
6/3/2025
Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer
6/2/2025
Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...
6/2/2025
OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...
Page:
1
/
15
Total number of articles:
431
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit